A Ardehali

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment
    Yaron Shargall
    Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada
    J Heart Lung Transplant 24:1489-500. 2005
  2. doi request reprint Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial
    Abbas Ardehali
    UCLA Medical Center, Los Angeles, CA, USA Electronic address
    Lancet 385:2577-84. 2015
  3. ncbi request reprint Gene therapy and heart transplantation
    A Ardehali
    UCLA Medical Center, 10833 Le Conte Avenue, CHS 62 232, Los Angeles, CA 90095, USA
    Expert Opin Investig Drugs 9:1021-7. 2000
  4. ncbi request reprint Modified reperfusion and ischemia-reperfusion injury in human lung transplantation
    Abbas Ardehali
    Division of Cardiothoracic Surgery, Department of Medicine, University of California at Los Angeles, USA
    J Thorac Cardiovasc Surg 126:1929-34. 2003
  5. ncbi request reprint Inhaled nitric oxide for pulmonary hypertension after heart transplantation
    A Ardehali
    Department of Surgery, UCLA Medical Center, Los Angeles 90095, USA
    Transplantation 72:638-41. 2001
  6. ncbi request reprint A prospective trial of inhaled nitric oxide in clinical lung transplantation
    A Ardehali
    Division of Cardiothoracic Surgery, Department of Surgery, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Transplantation 72:112-5. 2001
  7. ncbi request reprint CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model
    M P Fischbein
    Department of Surgery, UCLA School of Medicine, University of California at Los Angeles, 90095, USA
    Transplantation 71:1146-53. 2001
  8. pmc Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study
    S S Weigt
    Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 13:919-27. 2013
  9. pmc The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome
    A DerHovanessian
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Los Angeles, CA
    Am J Transplant 16:640-9. 2016
  10. ncbi request reprint Rantes production during development of cardiac allograft vasculopathy
    J J Yun
    Division of Cardiothoracic Surgery, Department of Surgery, UCLA School of Medicine, University of California at Los Angeles, USA
    Transplantation 71:1649-56. 2001

Collaborators

Detail Information

Publications55

  1. ncbi request reprint Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment
    Yaron Shargall
    Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada
    J Heart Lung Transplant 24:1489-500. 2005
  2. doi request reprint Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial
    Abbas Ardehali
    UCLA Medical Center, Los Angeles, CA, USA Electronic address
    Lancet 385:2577-84. 2015
    ..We aimed to assess the clinical outcomes of the Organ Care System compared with standard cold storage of human donor hearts for transplantation...
  3. ncbi request reprint Gene therapy and heart transplantation
    A Ardehali
    UCLA Medical Center, 10833 Le Conte Avenue, CHS 62 232, Los Angeles, CA 90095, USA
    Expert Opin Investig Drugs 9:1021-7. 2000
    ..This article will review the principles and current methodology of gene transfer technology, applications of gene transfer technology to allo- and xeno- transplantation and the current status of clinical trials on gene therapy...
  4. ncbi request reprint Modified reperfusion and ischemia-reperfusion injury in human lung transplantation
    Abbas Ardehali
    Division of Cardiothoracic Surgery, Department of Medicine, University of California at Los Angeles, USA
    J Thorac Cardiovasc Surg 126:1929-34. 2003
    ....
  5. ncbi request reprint Inhaled nitric oxide for pulmonary hypertension after heart transplantation
    A Ardehali
    Department of Surgery, UCLA Medical Center, Los Angeles 90095, USA
    Transplantation 72:638-41. 2001
    ....
  6. ncbi request reprint A prospective trial of inhaled nitric oxide in clinical lung transplantation
    A Ardehali
    Division of Cardiothoracic Surgery, Department of Surgery, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Transplantation 72:112-5. 2001
    ..We also hypothesized that if prophylactic NO proves ineffective in preventing RI then it may improve pulmonary hemodynamics and gas exchange in the subset of patients who develop RI...
  7. ncbi request reprint CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model
    M P Fischbein
    Department of Surgery, UCLA School of Medicine, University of California at Los Angeles, 90095, USA
    Transplantation 71:1146-53. 2001
    ..Chronic rejection, or cardiac allograft vasculopathy (CAV), remains the leading cause of late death in heart transplant recipients. The precise role and contributions of T lymphocyte subsets to CAV development remains unknown...
  8. pmc Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study
    S S Weigt
    Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 13:919-27. 2013
    ..Prospective evaluation of strategies to prevent Aspergillus colonization of small airways is warranted, with the goal of preserving lung allograft function as long as possible...
  9. pmc The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome
    A DerHovanessian
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Los Angeles, CA
    Am J Transplant 16:640-9. 2016
    ..These findings validate the association between PGD and the subsequent development of BOS, and suggest that this association may be mediated by receptor/TGF-β biology. ..
  10. ncbi request reprint Rantes production during development of cardiac allograft vasculopathy
    J J Yun
    Division of Cardiothoracic Surgery, Department of Surgery, UCLA School of Medicine, University of California at Los Angeles, USA
    Transplantation 71:1649-56. 2001
    ..Interventions aimed at inhibiting RANTES production in CAV may need to target several types of cells, and neutralization of RANTES bioactivity may reduce mononuclear cell recruitment and CAV development...
  11. pmc Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome
    S S Weigt
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 9:1903-11. 2009
    ....
  12. ncbi request reprint Cytoprotective gene HO-1 and chronic rejection in heart transplantation
    G T Schnickel
    Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA
    Transplant Proc 38:3259-62. 2006
    ..Induction of HO-1 by an apoA-1 mimetic peptide was effective to control CAV. This class of antiinflammatory peptides, which show an ability to induce HO-1, provides a novel strategy for the treatment of CAV...
  13. pmc CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction
    S S Weigt
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, at UCLA, Los Angeles, CA, USA
    Am J Transplant 12:477-84. 2012
    ..CXCR3 chemokine concentrations provide prognostic information and this may have important implications for the development of novel treatment strategies to modify outcomes after CARV infection...
  14. pmc Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft
    R Saggar
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 8:1921-30. 2008
    ..4%, p < 0.0001, and 77% vs. 35%, p = 0.004, respectively). PH is common in LT recipients with pathologic OB/BOS and is associated with a vasculopathy of the allograft pulmonary circulation...
  15. pmc Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation
    M Y Shino
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
    Am J Transplant . 2016
    ..Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response...
  16. pmc Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS
    A L Gregson
    Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA
    Am J Transplant 15:792-9. 2015
    ..Pseudomonas and elevated BALF concentrations of CXCL5 continued as significant risk factors for BOS and death after BOS in lung transplantation. ..
  17. ncbi request reprint Role of CXCR3 and CCR5 in allograft rejection
    G T Schnickel
    Division of Cardiac Surgery, Department of Surgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California 90095, USA
    Transplant Proc 38:3221-4. 2006
    ..We sought to determine the effect of combined blockade of CXCR3 and CCR5, two critical chemokine receptors, in acute rejection...
  18. pmc Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation
    S S Weigt
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 8:1512-22. 2008
    ..These results suggest a possible utility of BALF CC chemokines as biomarkers for guiding risk assessment during pulmonary CMV post-lung transplantation...
  19. pmc Systemic sclerosis and bilateral lung transplantation: a single centre experience
    R Saggar
    Division of Pulmonary and Critical Care Medicine, Dept of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1690, USA
    Eur Respir J 36:893-900. 2010
    ..AR rates may be significantly higher in the SSc group. Longer follow-up is necessary to determine the effects of gastrointestinal dysfunction and AR on late allograft function in SSc LTR...
  20. doi request reprint Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary
    M H Kwon
    Division of Cardiothoracic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA Electronic address
    Transplant Proc 46:1497-501. 2014
    ..We hypothesize that both undersized and oversized donor hearts fare equally well in this setting...
  21. ncbi request reprint CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants
    M P Fischbein
    Department of Microbiology, Immunology, and Molecular Genetics, Division of Cardiothoracic Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA
    J Immunol 165:7316-22. 2000
    ..Importantly, this study provides evidence that CD40 ligand-targeted therapies may prevent chronic rejection only in strain combinations where CD4(+) lymphocyte help is absolutely required...
  22. ncbi request reprint Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection
    James J Yun
    Department of Surgery, Division of Cardiothoracic Surgery, University of California at Los Angeles, Los Angeles, Calif, USA
    Circulation 109:932-7. 2004
    ..In this study, we sought to determine whether blockade of chemokine receptors CCR1 and CCR5 with Met-RANTES affects the development of CAV in a murine model...
  23. ncbi request reprint Role of CD8+ lymphocytes in chronic rejection of transplanted hearts
    Michael P Fischbein
    Division of Cardiothoracic Surgery, Department of Surgery, University of California, Los Angeles, UCLA Medical Center, Los Angeles, CA 90095, USA
    J Thorac Cardiovasc Surg 123:803-9. 2002
    ....
  24. ncbi request reprint Indirect alloreactivity and chronic rejection
    Abbas Ardehali
    Division of Cardiothoracic Surgery CHS 62 232, Department of Surgery, UCLA Medical Center, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095 aardehali mednet ucla edu
    Transplantation 73:1805-7. 2002
    ..Utilizing a murine model of cardiac allograft vasculopathy (CAV) and a recipient strain with markedly reduced capacity for indirect alloreactivity, we sought to define the importance of indirect allorecognition in CAV...
  25. pmc The role of MIG/CXCL9 in cardiac allograft vasculopathy
    James J Yun
    Division of Cardiothoracic Surgery, Department of Surgery, University of California at Los Angeles, Los Angeles, California, USA
    Am J Pathol 161:1307-13. 2002
    ..Neutralization of the chemokine MIG/CXCL9 may have therapeutic potential for the treatment of chronic rejection after heart transplantation...
  26. ncbi request reprint Seventeen-year experience with 1,083 heart transplants at a single institution
    Daniel Marelli
    Heart Transplant Program, University of California, Los Angeles, USA
    Ann Thorac Surg 74:1558-66; discussion 1567. 2002
    ..Heart transplantation is the most accepted treatment for end-stage heart disease. A review of 1,083 consecutive transplants (1984 to 2001) was undertaken...
  27. ncbi request reprint Use of two recipient lists for adults requiring heart transplantation
    Hillel Laks
    Heart Transplant Program, University of California, Los Angeles, Calif 90095 1741, USA
    J Thorac Cardiovasc Surg 125:49-59. 2003
    ..An alternate (second) adult recipient list was used to match excluded potential recipients with nonstandard donor hearts that would otherwise be unused...
  28. pmc Chemokines and transplant vasculopathy
    John A Belperio
    Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angele, CA 90095, USA
    Circ Res 103:454-66. 2008
    ..This report provides a comprehensive review of the chemokines that participate in the development of transplant vasculopathy...
  29. ncbi request reprint Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts
    Michael P Fischbein
    Department of Surgery, University of California, Los Angeles, USA
    J Thorac Cardiovasc Surg 126:216-23. 2003
    ..The purpose of this study was to determine the role of regulated interleukin-10 expression on the development of chronic rejection in heart transplantation, or cardiac allograft vasculopathy...
  30. ncbi request reprint Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides
    Roger Yu
    Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Curr Atheroscler Rep 10:171-6. 2008
    ..Published studies of apolipoprotein mimetic peptides in models of inflammatory disorders other than atherosclerosis suggest that they have efficacy in a wide range of inflammatory conditions...
  31. pmc Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection
    Aric L Gregson
    Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA 90095, USA
    Transplantation 85:1056-9. 2008
    ..A unique BALF lymphocyte profile was associated with rejection and may provide insight into the pathogenesis of allograft rejection...
  32. ncbi request reprint Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection
    Gabriel T Schnickel
    Department of Surgery, Division of Cardiothoracic Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Immunol 180:4714-21. 2008
    ..Combined CXCR3 and CCR5 blockade is effective in preventing acute and chronic rejection in a robust murine model. This effect is mediated, in part, by CD25(+) regulatory T cell recruitment and control of T lymphocyte proliferation...
  33. doi request reprint Lung transplantation in older patients?
    Raja Mahidhara
    Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, Calif 90095, USA
    J Thorac Cardiovasc Surg 135:412-20. 2008
    ..We sought to define the short- and medium-term outcome of lung transplantation in patients aged 65 years and older...
  34. pmc Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis
    David A Zisman
    Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
    Chest 133:640-5. 2008
    ..The objective of this study was to validate this method in a separate group of IPF patients...
  35. ncbi request reprint Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts
    George R Hsieh
    Division of Cardiac Surgery, Department of Surgery, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095, USA
    Transplantation 84:238-43. 2007
    ..Strategies to control CAV traditionally have focused on lymphocyte functions. We hypothesized that D-4F, an apoA-I mimetic peptide with potent anti-inflammatory/antioxidant properties, will attenuate CAV...
  36. pmc Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis
    David A Zisman
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Respir Med 101:2153-9. 2007
    ..We tested the hypothesis that the forced vital capacity to diffusing capacity ratio and room air resting pulse oximetry may be combined to predict mean pulmonary artery pressure (MPAP) in idiopathic pulmonary fibrosis...
  37. ncbi request reprint IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome
    Michael P Keane
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Immunol 178:511-9. 2007
    ..This supports the notion that IL-13 biological axis plays an important role during the pathogenesis of BOS independent of the IL-4 biological axis...
  38. ncbi request reprint Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation
    Jun Xu
    Division of Cardiology, UCLA Medical Center, 10833 Le Conte Ave, 47 123 CHS, Los Angeles, CA 90095 1679, USA
    Circulation 109:363-8. 2004
    ..However, the alteration of atrial extracellular matrix components during remodeling and its effect on the electrical remodeling and atrial arrhythmia have never been explored...
  39. ncbi request reprint Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production
    David Whiting
    Department of Surgery, Division of Cardiothoracic Surgery, David Geffen School of Medicine, University of California Los Angeles, UCLA Medical Center, 10833 LeConte Avenue, Los Angeles, CA 90095, USA
    J Immunol 172:7417-24. 2004
    ..This novel observation expands our current understanding of MIG/CXCL9 biology beyond that of mediating T cell trafficking...
  40. ncbi request reprint Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation
    David J Ross
    Division of Pulmonary and Critical Care Medicine and the Will Rogers Institute for Pulmonary Research, David Geffen School of Medicine U C L A Medical Center, Los Angeles, CA 90095 1690, USA
    Transplantation 78:1222-4. 2004
    ..We therefore speculate that complex interactions between adaptive and innate immunity may contribute to the propagation of airway inflammation in BOS...
  41. ncbi request reprint CD8 lymphocytes are sufficient for the development of chronic rejection
    Gabriel T Schnickel
    Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA
    Transplantation 78:1634-9. 2004
    ..The purposes of this study were to determine whether CD8 lymphocytes, in the absence of CD4 lymphocytes, are capable of causing the intimal lesions of CAV; and if so, to define the effector mechanism(s) of CD8 lymphocytes...
  42. pmc Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
    John A Belperio
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA
    J Clin Invest 115:1150-62. 2005
    ....
  43. ncbi request reprint Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study
    Fotios A Mitropoulos
    Heart Transplant Program, University of California, Los Angeles Medical Center, Los Angeles, CA, USA
    Eur J Cardiothorac Surg 28:143-8. 2005
    ..Early graft failure and potential relation to transplant coronary artery disease remains a concern. We sought to evaluate outcomes of heart transplantation in recipients of donor allografts with prolonged ischemia time...
  44. ncbi request reprint CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury
    John A Belperio
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, 90095, USA
    J Immunol 175:6931-9. 2005
    ....
  45. ncbi request reprint Modified reperfusion in clinical lung transplantation: the results of 100 consecutive cases
    Gabriel T Schnickel
    Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Calif, USA
    J Thorac Cardiovasc Surg 131:218-23. 2006
    ..We hypothesized that altering the content of the initial reperfusate and maintaining a low reperfusion pressure after surgical implantation would lead to a low incidence of primary graft dysfunction...
  46. ncbi request reprint Liberalization of donor criteria in lung transplantation
    David Whiting
    Department of Surgery, Division of Cardiothoracic Surgery, David Geffea School of Medicine at UCLA, Los Angeles, California 90095, USA
    Am Surg 69:909-12. 2003
    ..The 3-month survival was 97.6 per cent. Selective liberalization of donor lung criteria can decrease the waiting time and is associated with favorable short-term outcome. Utilization of nonstandard lungs can expand the donor pool...
  47. ncbi request reprint Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection
    John A Belperio
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California School of Medicine, Los Angeles, CA 90095, USA
    J Immunol 171:4844-52. 2003
    ..This supports the notion that CXCL9 interaction with cells expressing CXCR3 has an important role in the recruitment of mononuclear cells, a pivotal event in the pathogenesis of acute lung allograft rejection...
  48. pmc High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis
    David A Zisman
    Department of Medicine, David Geffen School of Medicine at UCLA, 37 131 Center for Health Sciences, Los Angeles, CA 90095, USA
    Chest 132:773-9. 2007
    ..We tested the hypothesis that chest CT-determined extent of pulmonary fibrosis and/or main pulmonary artery diameter (MPAD) can be used to identify the presence of PH in patients with advanced IPF...
  49. ncbi request reprint Results after transplantation using donor hearts with preexisting coronary artery disease
    Daniel Marelli
    Division of Cardiothoracic Surgery, Heart Transplant Program, UCLA School of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095 1741, USA
    J Thorac Cardiovasc Surg 126:821-5. 2003
    ..Twenty-two recipients who received donor hearts with mild to moderate coronary artery disease on angiography were reviewed. All donor organs had preserved left ventricle function on echocardiogram...
  50. doi request reprint Long-term outcomes of heart transplantation in older recipients
    Daniel Marelli
    David Geffen School of Medicine, Heart Transplant Program, University of California, Los Angeles, Los Angeles, California, USA
    J Heart Lung Transplant 27:830-4. 2008
    ..We evaluated outcomes from one institution with the hypothesis that older recipients may be at higher risk of major complications associated with immunosuppression...
  51. ncbi request reprint Collective review: perioperative uses of inhaled nitric oxide in adults
    Mehmet C Oz
    Columbia University College of Physicians and Surgeons, New York, New York
    Heart Surg Forum 7:E584-9. 2004
    ..This review focuses on the multiple clinical applications of iNO in perioperative patient care...
  52. ncbi request reprint Use of a donor heart with symptomatic WPW in an alternate donor program
    John Kao
    Department of Medicine, Division of Cardiology, 47 123 CHS, UCLA School of Medicine, Los Angeles, CA 90095, USA
    J Heart Lung Transplant 21:1310-3. 2002
  53. ncbi request reprint Short-term bridge to heart transplant using the BVS 5000 external ventricular assist device
    Feng Chun Tsai
    University of California, Los Angeles, Heart Transplant Program, UCLA School of Medicine, 90095 1741, USA
    Am J Transplant 2:646-51. 2002
    ..Short-term bridge to transplantation using the BVS 5000 is feasible in selected patients. Caution is recommended when directing such patients to transplant if they need ventilator support and have high serum bilirubin levels...
  54. ncbi request reprint Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs
    Feng Chun Tsai
    Heart Transplant Program, University of California, Los Angeles, Center for Health Sciences, 90095 1741, USA
    Am J Transplant 2:539-45. 2002
    ..Early mortality tends to reflect graft failure while hospital mortality may be more indicative of recipient selection...
  55. ncbi request reprint Mycobacterium abscessus empyema in a lung transplant recipient
    Rick M Fairhurst
    Division of Infectious Diseases, Department of Medicine, UCLA Medical Center, Los Angeles, California 90095, USA
    J Heart Lung Transplant 21:391-4. 2002
    ..We report a case of Mycobacterium abscessus empyema in a lung transplant recipient. Repeated attempts at identifying the organism from a variety of clinical specimens led to the correct diagnosis and treatment...